Variant report
Variant | nsv973097 |
---|---|
Chromosome Location | chr12:83544133-83545969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:53)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr12:83543919-83544914 | K562 | blood: | n/a | n/a |
2 | BCLAF1 | chr12:83544132-83544573 | K562 | blood: | n/a | n/a |
3 | BCLAF1 | chr12:83544125-83544611 | K562 | blood: | n/a | n/a |
4 | CCNT2 | chr12:83544274-83544770 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr12:83544426-83544965 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr12:83544479-83544860 | Hela-S3 | cervix: | n/a | n/a |
7 | CEBPB | chr12:83544488-83544736 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr12:83544446-83544865 | K562 | blood: | n/a | n/a |
9 | CEBPD | chr12:83544205-83545050 | K562 | blood: | n/a | n/a |
10 | CEBPD | chr12:83544238-83545032 | K562 | blood: | n/a | n/a |
11 | CTCF | chr12:83544941-83544961 | Medullo | brain: | n/a | n/a |
12 | CTCF | chr12:83544849-83545175 | K562 | blood: | n/a | n/a |
13 | CTCF | chr12:83545712-83545799 | GM13976 | blood: | n/a | n/a |
14 | CUX1 | chr12:83544641-83544877 | K562 | blood: | n/a | n/a |
15 | EBF1 | chr12:83544554-83544570 | GM12878 | blood: | n/a | n/a |
16 | EGR1 | chr12:83544299-83544546 | K562 | blood: | n/a | chr12:83544418-83544440 |
17 | EGR1 | chr12:83544263-83544549 | K562 | blood: | n/a | chr12:83544418-83544440 |
18 | EP300 | chr12:83544344-83544626 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr12:83544313-83545012 | K562 | blood: | n/a | n/a |
20 | EP300 | chr12:83544585-83545000 | SK-N-SH_RA | brain: | n/a | n/a |
21 | GATA2 | chr12:83544381-83545249 | SH-SY5Y | brain: | n/a | n/a |
22 | GATA2 | chr12:83544419-83545000 | K562 | blood: | n/a | n/a |
23 | GATA2 | chr12:83544550-83544811 | K562 | blood: | n/a | n/a |
24 | GATA3 | chr12:83544408-83545055 | SK-N-SH | brain: | n/a | n/a |
25 | GATA3 | chr12:83544511-83545039 | SK-N-SH | brain: | n/a | n/a |
26 | GATA3 | chr12:83544521-83544956 | SH-SY5Y | brain: | n/a | n/a |
27 | GTF2B | chr12:83544411-83544612 | K562 | blood: | n/a | n/a |
28 | GTF2F1 | chr12:83544399-83544599 | K562 | blood: | n/a | n/a |
29 | HEY1 | chr12:83544198-83544557 | K562 | blood: | n/a | n/a |
30 | HEY1 | chr12:83544017-83544554 | K562 | blood: | n/a | n/a |
31 | JUND | chr12:83544331-83545000 | K562 | blood: | n/a | n/a |
32 | MAFK | chr12:83544718-83544973 | HepG2 | liver: | n/a | n/a |
33 | NR2F2 | chr12:83544593-83545011 | K562 | blood: | n/a | n/a |
34 | PML | chr12:83544017-83545040 | K562 | blood: | n/a | n/a |
35 | PML | chr12:83544033-83544649 | K562 | blood: | n/a | n/a |
36 | POLR2A | chr12:83544154-83544528 | K562 | blood: | n/a | n/a |
37 | POLR2A | chr12:83544071-83544623 | K562 | blood: | n/a | n/a |
38 | POLR2A | chr12:83544122-83544602 | K562 | blood: | n/a | n/a |
39 | POLR2A | chr12:83544127-83544566 | K562 | blood: | n/a | n/a |
40 | POLR2A | chr12:83544053-83544627 | K562 | blood: | n/a | n/a |
41 | POLR2A | chr12:83544152-83544613 | K562 | blood: | n/a | n/a |
42 | POLR2A | chr12:83544636-83544938 | K562 | blood: | n/a | n/a |
43 | RCOR1 | chr12:83544248-83545013 | K562 | blood: | n/a | n/a |
44 | STAT5A | chr12:83544309-83544951 | K562 | blood: | n/a | chr12:83544930-83544942 chr12:83544647-83544662 |
45 | TAF7 | chr12:83544211-83544657 | K562 | blood: | n/a | n/a |
46 | TAF7 | chr12:83544312-83544499 | K562 | blood: | n/a | n/a |
47 | TAL1 | chr12:83543885-83545096 | K562 | blood: | n/a | n/a |
48 | TBL1XR1 | chr12:83544263-83545075 | K562 | blood: | n/a | n/a |
49 | TBP | chr12:83544285-83544699 | K562 | blood: | n/a | n/a |
50 | TEAD4 | chr12:83544153-83545129 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:83542880..83544504-chr12:83556939..83559437,2 | K562 | blood: | |
2 | chr12:83542565..83545008-chr12:83566532..83568731,2 | K562 | blood: | |
3 | chr12:83544204..83547300-chr12:83565294..83568288,4 | K562 | blood: | |
4 | chr12:83531135..83533652-chr12:83540992..83544898,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL6P25 | TF binding region |
ENSG00000258338 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544682616 | chr12:83544161-83544162 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs543822793 | chr12:83544215-83544216 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs542762256 | chr12:83544263-83544264 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs561027731 | chr12:83544269-83544270 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs144997459 | chr12:83544292-83544293 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs563408187 | chr12:83544299-83544300 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs543379048 | chr12:83544310-83544311 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs61929931 | chr12:83544327-83544328 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs533030393 | chr12:83544342-83544343 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs542389755 | chr12:83544372-83544373 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs551560312 | chr12:83544381-83544382 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs375659279 | chr12:83544472-83544473 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs368965208 | chr12:83544496-83544497 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs527478477 | chr12:83544534-83544535 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs17010672 | chr12:83544558-83544559 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs149095610 | chr12:83544564-83544565 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs184932131 | chr12:83544565-83544566 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs556165640 | chr12:83544580-83544581 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs1914518 | chr12:83544620-83544621 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs549147937 | chr12:83544651-83544652 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs116225779 | chr12:83544654-83544655 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs189967234 | chr12:83544677-83544678 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs11115620 | chr12:83544686-83544687 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs542798769 | chr12:83544704-83544705 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs554660119 | chr12:83544713-83544714 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs560948816 | chr12:83544747-83544748 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs530394938 | chr12:83544759-83544760 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs77507222 | chr12:83544832-83544833 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs543415814 | chr12:83544857-83544858 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs377636755 | chr12:83544885-83544886 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs577158570 | chr12:83544891-83544892 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs371052791 | chr12:83544895-83544896 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs1517812 | chr12:83544897-83544898 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs560373197 | chr12:83544917-83544918 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs527513971 | chr12:83544926-83544927 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs181232736 | chr12:83544986-83544987 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs187138260 | chr12:83544995-83544996 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs113611756 | chr12:83545016-83545017 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs571454111 | chr12:83545033-83545034 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs571203057 | chr12:83545096-83545097 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs191574701 | chr12:83545097-83545098 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs141870521 | chr12:83545114-83545115 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs145630686 | chr12:83545115-83545116 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs566330286 | chr12:83545134-83545135 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs12307071 | chr12:83545139-83545140 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs138245079 | chr12:83545140-83545141 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs79360094 | chr12:83545173-83545174 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs142849992 | chr12:83545188-83545189 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs150651878 | chr12:83545203-83545204 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs577196345 | chr12:83545216-83545217 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:83540000-83544800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr12:83543400-83545000 | Enhancers | K562 | blood |
3 | chr12:83543600-83548400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr12:83543800-83548200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr12:83544400-83544800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr12:83544400-83545200 | Enhancers | Hela-S3 | cervix |
7 | chr12:83544600-83545200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr12:83544800-83545000 | Enhancers | Right Atrium | heart |
9 | chr12:83544800-83547400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr12:83545000-83550400 | Weak transcription | K562 | blood |
11 | chr12:83545200-83547200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr12:83545200-83550400 | Weak transcription | Hela-S3 | cervix |
13 | chr12:83545800-83546400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr12:83545800-83546600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr12:83545800-83547000 | Enhancers | HUES48 Cell Line | embryonic stem cell |